Skip to main content
NIH funding notice RFA-CA-21-003

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

Closed on September 29, 2021.

Posted
November 20, 2020
Close date
September 29, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
16
16 new
Median first-year cost
$214,120
$3,597,193 in all
Institutions
15
16 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. DUKE UNIVERSITY2
  2. BRIGHAM YOUNG UNIVERSITY1
  3. BROAD INSTITUTE, INC.1
  4. CARNEGIE-MELLON UNIVERSITY1
  5. COLUMBIA UNIV NEW YORK MORNINGSIDE1

and 10 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 TCRB-J (O1))7
  2. Special Emphasis Panel (ZCA1 TCRB-D (M1))5
  3. Special Emphasis Panel (ZCA1 TCRB-D (J1))4
16 awards under RFA-CA-21-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer1R21CA272345-01Knowles, David ArthurNEW YORK GENOME CENTER, NYFirst-year cost $353,190Study section ZCA1
FY2022A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage1R21CA257980-01A1Belcher, Angela M.Maley, CarloMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MAFirst-year cost $297,248Study section ZCA1
FY2022Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential1R21CA258008-01A1Konstantopoulos, KonstantinosMartin, Stuart SScarcelli, GiulianoUNIV OF MARYLAND, COLLEGE PARK, MDFirst-year cost $284,383Study section ZCA1
FY2022A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors1R21CA257942-01A1Gibbs, Summer LynneOREGON HEALTH & SCIENCE UNIVERSITY, ORFirst-year cost $245,722Study section ZCA1
FY2022Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA1R21CA267260-01Armitage, Bruce A.Zhang, HuaiyingCARNEGIE-MELLON UNIVERSITY, PAFirst-year cost $226,898Study section ZCA1
FY2022Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color1R21CA267012-01Snyder, Joshua ClairDUKE UNIVERSITY, NCFirst-year cost $224,075Study section ZCA1
FY2022Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy1R21CA272351-01Soper, Steven AllanUNIVERSITY OF KANSAS LAWRENCE, KSFirst-year cost $222,005Study section ZCA1
FY2022Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy1R21CA269099-01Berezin, Mikhail Y.Yakovlev, Vladislav V.TEXAS ENGINEERING EXPERIMENT STATION, TXFirst-year cost $217,181Study section ZCA1
FY2022Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix1R21CA261642-01A1Gao, YuNaba, AlexandraUNIVERSITY OF ILLINOIS AT CHICAGO, ILFirst-year cost $211,059Study section ZCA1
FY2022Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout1R21CA269103-01Blainey, Paul ClarkBROAD INSTITUTE, INC., MAFirst-year cost $207,784Study section ZCA1
FY20223D Fourier Imaging System for High Throughput Analyses of Cancer Organoids1R21CA267222-01Lee, HakhoMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $196,350Study section ZCA1
FY2022A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies1R21CA261775-01A1Lin, QiaoCOLUMBIA UNIV NEW YORK MORNINGSIDE, NYFirst-year cost $191,869Study section ZCA1
FY2022Adapting K-MDS to detect KRAS-mutant ctDNA1R21CA257816-01A1Abbruzzese, James L.Counter, Christopher MDUKE UNIVERSITY, NCFirst-year cost $188,169Study section ZCA1
FY2022Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations1R21CA272014-01Salipante, Stephen JUNIVERSITY OF WASHINGTON, WAFirst-year cost $181,741Study section ZCA1
FY2022High-throughput inverted reporter assay for characterization of silencers and enhancer blockers1R21CA257864-01A1Boyle, Alan PUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $175,343Study section ZCA1
FY2022In-depth and label-free proteome profiling of hundreds of single cells per day1R21CA272326-01Kelly, Ryan TBRIGHAM YOUNG UNIVERSITY, UTFirst-year cost $174,176Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-21-003: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience